Webinar | Controlling potentially mutagenic impurities – hear from industry experts!

We were delighted to welcome Andrew Teasdale PhD and Muzaffar Khan PhD to present within our webinar; Controlling potentially mutagenic impurities – hear from industry experts! Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity […]

Webinar | Controlling potentially mutagenic impurities – hear from industry experts! Read More »